Clinical trial

24-hr Intraocular Pressure Control With SIMBRINZA ®

NCT02770248

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2016-05-23

PhasePHASE4

Study timeline

Study start (actual)2016-05-23Date precision: day

Registry last updated2018-07-02

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Glaucomaunresolved

Interventions

Brinzolamide 1%/brimonidine 0.2% tartrate ophthalmic suspensionDRUG

VehicleDRUG

Sponsors & collaborators

Alcon Researchlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02770248 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.